The global contraceptives market was valued at $26,321.5 million in 2020 and is projected to reach $50,595.8 million by 2030, growing at a CAGR of 6.5% from 2020 to 2030.
Contraception is a method of preventing pregnancy using drugs or a device. It is also known as birth control and fertility control. The devices or drugs used in contraception interfere with the normal process of sperm-ovum fertilization to prevent pregnancy.
Rise in focus towards the need of family planning and preventing unintended pregnancy fuels the market growth. In addition, increase in use of contraception in young women and rise in higher educational attainment propels the market growth. Moreover, health issues associated with teenage pregnancies, increase in awareness of modern contraception, and rise in use of oral pills as a key method to avoid unplanned pregnancy further drive the contraceptives market growth.
High absorption rate, and rise in participation of reproductive women in labor force, and high awareness about contraceptive products among population, which drives the growth of the global contraceptive market. In addition, rise in disposable income of population in developing countries such as India, Brazil, Africa, and others, which in turn, rise in adoption of contraceptives products, boost the growth of the global contraceptives market. For instance, the disposable income of Indian population grew by 1.8% from 2019 to 2021.
However, health risks associated with the use of contraceptives, availability of alternate contraceptive methods, and lack of social acceptance might adversely affect the contraceptives market growth.
Major players such as Cooper Companies, Veru Inc., Pfizer Inc. and others are adopting the acquisition strategy to improve their product portfolio to maintain competition in the market. For instance, in March 2021, Cooper completed the acquisition of a privately-held medical device company that designed and developed an innovative obstetric product for use in urgent obstetrics to reduce risks associated with childbirth. Such instances are expected to provide lucrative opportunities for the major players for the growth of the market.
The contraceptives market is segmented on the basis of product, age group, end user, and geography. Contraceptive drugs and devices are two major product categories of the contraceptives market. Contraceptive drugs are further categorized into oral (pills), injectable, and topical contraceptives. The oral contraceptives industry is the largest within the contraceptive drug market owing to the widespread use of oral pills by women. This is mainly because they are proven to be highly effective, up to 99% in preventing pregnancy. Drugs segment generated the highest revenue in 2020.
In addition, contraceptive devices are further categorized into condoms, IUDs, diaphragms, sponges, patches, implants, and vaginal rings. In terms of revenue, condoms are the most commonly used contraceptive devices, accounting for around two-thirds of the contraceptives market share in 2020. However, IUDs’ gain momentum and are expected to grow at a faster pace during the forecasting period. By age group, the market is divided into 15-44 years, and above 44 years. 15-44 years segment dominate the market in 2020.
On the basis of end user, the market is segmented into households, clinics, and hospitals. Households segment generated the highest revenue in 2020.
The COVID-19 pandemic forced many companies in the global contraceptives market to halt business operations for a short term to comply with new government regulations to curb the spread of the disease. This halt in operations directly impacts revenue flow of the global contraceptives market. In addition, halt in manufacturing of industrial products was witnessed due to lack of raw materials and manpower das lockdowns were imposed during the COVID-19 pandemic. Further, no new consignments were received by companies operating in this sector. Hence, halt in industrial activities and lockdowns for several months affected the global contraceptives market and the market is anticipated to witness a slow recovery during the forecast period.
By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America region is expected to hold the highest market share during the forecast period.
The report provides a comprehensive analysis of the key players that operate in the contraceptives market, namely, Veru Inc., Teva Pharmaceutical Industries Limited, Abbvie Inc., Bayer AG, Pfizer, Inc., Cooper Companies, Inc., Ansell LTD., Mayer Laboratories, Merck & Co., Inc., and Church & Dwight, Co., Inc.
Contraception is a method of preventing pregnancy using drugs or a device. It is also known as birth control and fertility control. The devices or drugs used in contraception interfere with the normal process of sperm-ovum fertilization to prevent pregnancy.
Rise in focus towards the need of family planning and preventing unintended pregnancy fuels the market growth. In addition, increase in use of contraception in young women and rise in higher educational attainment propels the market growth. Moreover, health issues associated with teenage pregnancies, increase in awareness of modern contraception, and rise in use of oral pills as a key method to avoid unplanned pregnancy further drive the contraceptives market growth.
High absorption rate, and rise in participation of reproductive women in labor force, and high awareness about contraceptive products among population, which drives the growth of the global contraceptive market. In addition, rise in disposable income of population in developing countries such as India, Brazil, Africa, and others, which in turn, rise in adoption of contraceptives products, boost the growth of the global contraceptives market. For instance, the disposable income of Indian population grew by 1.8% from 2019 to 2021.
However, health risks associated with the use of contraceptives, availability of alternate contraceptive methods, and lack of social acceptance might adversely affect the contraceptives market growth.
Major players such as Cooper Companies, Veru Inc., Pfizer Inc. and others are adopting the acquisition strategy to improve their product portfolio to maintain competition in the market. For instance, in March 2021, Cooper completed the acquisition of a privately-held medical device company that designed and developed an innovative obstetric product for use in urgent obstetrics to reduce risks associated with childbirth. Such instances are expected to provide lucrative opportunities for the major players for the growth of the market.
The contraceptives market is segmented on the basis of product, age group, end user, and geography. Contraceptive drugs and devices are two major product categories of the contraceptives market. Contraceptive drugs are further categorized into oral (pills), injectable, and topical contraceptives. The oral contraceptives industry is the largest within the contraceptive drug market owing to the widespread use of oral pills by women. This is mainly because they are proven to be highly effective, up to 99% in preventing pregnancy. Drugs segment generated the highest revenue in 2020.
In addition, contraceptive devices are further categorized into condoms, IUDs, diaphragms, sponges, patches, implants, and vaginal rings. In terms of revenue, condoms are the most commonly used contraceptive devices, accounting for around two-thirds of the contraceptives market share in 2020. However, IUDs’ gain momentum and are expected to grow at a faster pace during the forecasting period. By age group, the market is divided into 15-44 years, and above 44 years. 15-44 years segment dominate the market in 2020.
On the basis of end user, the market is segmented into households, clinics, and hospitals. Households segment generated the highest revenue in 2020.
The COVID-19 pandemic forced many companies in the global contraceptives market to halt business operations for a short term to comply with new government regulations to curb the spread of the disease. This halt in operations directly impacts revenue flow of the global contraceptives market. In addition, halt in manufacturing of industrial products was witnessed due to lack of raw materials and manpower das lockdowns were imposed during the COVID-19 pandemic. Further, no new consignments were received by companies operating in this sector. Hence, halt in industrial activities and lockdowns for several months affected the global contraceptives market and the market is anticipated to witness a slow recovery during the forecast period.
By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America region is expected to hold the highest market share during the forecast period.
The report provides a comprehensive analysis of the key players that operate in the contraceptives market, namely, Veru Inc., Teva Pharmaceutical Industries Limited, Abbvie Inc., Bayer AG, Pfizer, Inc., Cooper Companies, Inc., Ansell LTD., Mayer Laboratories, Merck & Co., Inc., and Church & Dwight, Co., Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the contraceptives market analysis from 2020 to 2030 to identify the prevailing contraceptives market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the contraceptives market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global contraceptives market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
- Drugs
- Devices
By Age Group
- 15-44 Years
- Above 44 Years
By End User
- Households
- Clinics
- Hospitals
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- Italy
- France
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
Key Market Players
- Merck & Co Inc
- Pfizer Inc
- Abbvie Inc
- Ansell Ltd
- Bayer AG
- Church & Dwight Co Inc
- Teva Pharmaceutical Industries Limited
- The Cooper Companies Inc
- Veru Inc
- Mayer Laboratories Inc
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: CONTRACEPTIVES MARKET, BY PRODUCT TYPE
CHAPTER 5: CONTRACEPTIVES MARKET, BY AGE GROUP
CHAPTER 6: CONTRACEPTIVES MARKET, BY END USER
CHAPTER 7: CONTRACEPTIVES MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Contraceptives Market,' the contraceptives market size was valued at $26,321.50 million in 2020, and is estimated to reach $50.6 Billion by 2030, growing at a CAGR of 6.5% from 2021 to 2030.The use of advanced contraceptive methods and emergency contraceptives methods, especially for teenagers, and increase in awareness regarding sexually transmitted infections (STIs) are the major factors responsible for the growth of the contraceptives market. Increase in popularity of female condoms, custom-fit condoms, and other novel products fuels the demand for contraceptives, especially in developed regions. Furthermore, rise in adoption of modern contraceptives in the developing economies has significantly contributed to the market growth. However, sociocultural influences of contraceptives and side effects, such as infertility resulting from the use of contraception are the major impediments to the market growth.
The contraceptives market is segmented based on product, age group, end user, and geography. On the basis of product, the market is classified into drugs and devices. The drugs segment dominated the market in 2020. By age group, the market is divided into 15-44 years, and above 44 years. 15-44 years segment dominated the market in 2020. By end user, the market is segmented into households, hospitals, and clinics. The households segment dominated the market in 2020.
The condoms segment is expected to dominate the overall contraceptives device market during the forecast period, due to increase in their demand in developed as well as developing economies. Male condoms are more popular than female condoms, which significantly boosts the growth of the overall contraceptive market. Increase in popularity of male condoms is attributed to their easy accessibility, ease-of-use, and wide acceptance across various regions.
Contraceptives market analysis is done on the basis of age group, product type, and end user. On the basis of age group, women in the age group of 15-24 years are the major revenue contributors to the contraceptive market. This is attributed to the increased usage of contraceptives among teenagers, early maturity among teenage girls, and rising demand for contraceptives. However, women aged above 44 years are the least contributors to the contraceptives market growth due to the menopause in women at the age 44 years and above. Above 44 years segment has highest contraceptives market share.
On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for majority share in the contraceptives market in 2020. This market is expected to maintain its lead during the forecast period due to increase in awareness among the population, upsurge in adoption of modern contraceptives, and rise in prevalence of sexually transmitted diseases such as HIV/AIDS. Contraceptives market forecast from 2020 to 2030.
The U.S. contraceptive market accounts for the largest share in the overall North America contraceptive market. Asia-Pacific region is expected to grow at the fastest pace during the study period, owing to high population base and proactive initiatives of governmental organization for birth control. Moreover, technological advancements and cost-effective contraceptive products in these regions offer lucrative opportunities to contraceptive manufacturers. Initiatives taken by regulatory bodies and government organizations to mandate the use of barrier contraceptives, such as condoms, have significant impact on the growth of the contraceptive market. Contraceptive methods for home use are effective and convenient, owing to the cost-effectiveness of these products. Advancements in contraceptive techniques and launch of awareness programs by government agencies and other regulatory bodies to increase household usage of contraceptives drive the markets in Asia-Pacific and LAMEA regions. Asia-Pacific region has highest contraceptives market size.
The report provides a comprehensive analysis of the key players that operate in the contraceptives market, namely, Veru Inc., Teva Pharmaceutical Industries Limited, Abbvie Inc., Bayer AG, Pfizer, Inc., Cooper Companies, Inc., Ansell LTD., Mayer Laboratories, Merck & Co., Inc., and Church & Dwight, Co., Inc.
Several manufacturers in the global contraceptives industry stopped their business activities in 2020 due to lockdowns implemented in developed and developing countries, owing to ban on industrial activities due to the COVID-19 pandemic. This halt in production activities impacted the revenue of the contraceptives manufacturing companies. For instance, net sales of Teva Pharmaceuticals Industries Limited dropped by 4.7% from January 2021 to December 2021. In addition, lack of man power and raw materials affected the supply chain of the global contraceptives market. However, the market is projected to cover from the 1st quarter of 2023, due to reduced restrictions and reopening of the global contraceptives industry. Moreover, in 2021, with the availability of vaccine against COVID-19, the market re-opened at full pace with a start of 2022.
Companies Mentioned
- Merck & Co Inc
- Pfizer Inc
- Abbvie Inc
- Ansell Ltd
- Bayer AG
- Church & Dwight Co Inc
- Teva Pharmaceutical Industries Limited
- The Cooper Companies Inc
- Veru Inc
- Mayer Laboratories Inc
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 192 |
| Published | March 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 26321.5 million |
| Forecasted Market Value ( USD | $ 50595.8 million |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
